Variable | CAP (n = 68) | HCAP (n = 74) | HAP (n = 134) | p value | ||
---|---|---|---|---|---|---|
CAP vs. HCAP | HCAP vs. HAP | CAP vs. HAP | ||||
Amikacin | 0 (0.0) | 0 (0.0) | 6 (4.5) | N/A | 0.091 | 0.099 |
Gentamicin | 3 (4.4) | 13 (17.6) | 22 (16.4) | 0.016 | 0.832 | 0.013 |
Cefuroxime | 7 (10.3) | 27 (36.5) | 64 (47.8) | < 0.001 | 0.117 | < 0.001 |
3rd generation cephalosporina | 5 (7.4) | 19 (25.7) | 57 (42.5) | 0.004 | 0.016 | < 0.001 |
Ciprofloxacin | 3 (4.4) | 22 (29.7) | 52 (38.8) | < 0.001 | 0.191 | < 0.001 |
Levofloxacin | 3 (4.4) | 22 (29.7) | 51 (38.1) | < 0.001 | 0.228 | < 0.001 |
Ertapenem | 2 (2.9) | 11 (14.9) | 33 (24.6) | 0.018 | 0.099 | < 0.001 |
Imipenem | 0 (0.0) | 0 (0.0) | 7 (5.2) | N/A | 0.052 | 0.098 |
Tigecycline | 2 (2.9) | 1 (1.4) | 10 (7.5) | 0.607 | 0.101 | 0.344 |
Wild-type antibiotic susceptibilityb | 60 (88.2) | 40 (54.1) | 58 (43.3) | < 0.001 | 0.149 | < 0.001 |
Multidrug resistancec | 7 (10.3) | 27 (36.5) | 66 (49.3) | < 0.001 | 0.076 | < 0.001 |